These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 75796)

  • 21. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
    Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
    N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-Fetoprotein and early histological changes of hepatic tissue in DAB-hepatocarcinogenesis.
    Onoé T; Kaneko A; Dempo K; Ogawa K; Minase T
    Ann N Y Acad Sci; 1975 Aug; 259():168-80. PubMed ID: 54019
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
    Chen DS; Sung FL
    Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
    [No Abstract]   [Full Text] [Related]  

  • 24. [Alpha fetoprotein in hepatocarcinoma].
    Segura JM; Pérez-Jiménez F; De Dios J; Cerezo E; Muro J
    Rev Clin Esp; 1977 Oct; 147(1):73-5. PubMed ID: 73206
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)].
    Kao MC; Yin SJ; Lee SC; Lin CY; Cheng TC; Fong MS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):1032-7. PubMed ID: 6166727
    [No Abstract]   [Full Text] [Related]  

  • 27. The diagnostic importance of alpha-fetoprotein.
    Ojwang PJ
    East Afr Med J; 1991 Aug; 68(8):593-4. PubMed ID: 1722451
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
    Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
    Tanabe Y; Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1988 Dec; 83(12):1386-9. PubMed ID: 2461655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
    Huo TI; Lee SD
    Liver Int; 2006 Dec; 26(10):1300-1. PubMed ID: 17105599
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
    Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W
    Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095
    [No Abstract]   [Full Text] [Related]  

  • 32. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 33. Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
    Terada R; Yamamoto K; Sakaguchi K; Kiyotoshi S; Yagi T; Sadamori H; Tsuji T
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1310-1. PubMed ID: 11903755
    [No Abstract]   [Full Text] [Related]  

  • 34. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
    Peng SY; Lai PL; Chu JS; Lee PH; Tsung PT; Chen DS; Hsu HC
    Hepatology; 1993 Jan; 17(1):35-41. PubMed ID: 7678574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
    Wong IH; Lo YM; Lai PB; Johnson PJ
    Clin Chem; 2000 Sep; 46(9):1420-2. PubMed ID: 10973879
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
    Nagasue N; Yukaya H; Chang YC; Ogawa Y
    Cancer; 1986 May; 57(9):1820-3. PubMed ID: 2420438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis].
    Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Kameda H
    Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2363-8. PubMed ID: 6200631
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha1-fetoprotein in liver disease in Sarawak.
    Kothare SN
    Singapore Med J; 1978 Dec; 19(4):220-4. PubMed ID: 87015
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B antigen and alpha fetoprotein in the sera of patients with hepatocellular carcinoma.
    Rajagopalan N; Sama SK; Krishnamurthy L; Gandhi G; Nayak NC
    Indian J Med Res; 1977 Jan; 65(1):95-100. PubMed ID: 68001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.